
Australia partners with Anthropic for responsible AI
The Albanese Government has formalised a landmark partnership with global AI lab Anthropic, signing a memorandum of understanding to accelerate the responsible adoption of artificial intelligence across the Australian economy.
Finalised during a high-level meeting between Prime Minister Anthony Albanese and Anthropic CEO Dario Amodei, the agreement marks the first major international collaboration under the federal government’s 2025 National AI Plan.
The MoU outlines five priority areas, including tracking frontier AI progress, promoting supply chain security, and enhancing national productivity, with a specific focus on the natural resources, agriculture, healthcare, and financial services sectors.
As part of the initiative, Anthropic announced it is providing $3 million in Claude API credits to leading research institutions, including the Australian National University and the Garvan Institute of Medical Research, to bolster domestic scientific innovation.
The company is exploring significant investments in Australian data centre infrastructure and renewable energy, aligning with the government's recently released expectations for AI sovereign capability.
The partnership arrives at a pivotal moment for Anthropic, which is currently embroiled in a federal lawsuit against the US Pentagon.
The legal dispute follows a "supply chain risk" designation triggered by Anthropic's refusal to allow its models to be used for autonomous weaponry or mass surveillance.
By contrast, Industry Minister Tim Ayres noted that the Australian agreement sends a "clear signal" that the nation is open for business with technology partners whose safety protocols align with Australian values and national interests.
Frequently asked questions
More from Australia
Titanium Sands secures $500,000 Sri Lankan funding
WIN Metals expands Butchers Creek gold tenure package
Forte Energy enters South American oil exploration agreement
Pathkey.AI validates Chipforge platform through independent testing
Arovella Therapeutics names acting CEO
Ingenia Communities rejects new Warburg Pincus buyback offer